Related Experiment Videos
Triphenyl tin hepatotoxicity in rats
Summary
Triphenyl tin (TPT) treatment in rats significantly reduced liver enzyme activity and sulfobromophthalein (BSP) biliary excretion. This suggests reduced glutathione conjugation may impair BSP transport in the liver.
Area of Science:
- Toxicology
- Hepatology
- Drug Metabolism
Background:
- Triphenyl tin (TPT) is a known organotin compound.
- Hepatic microsomal enzymes and biliary excretion are critical for xenobiotic metabolism and elimination.
Purpose of the Study:
- To investigate the effects of triphenyl tin (TPT) on hepatic microsomal enzyme activities and biliary excretion in rats.
- To explore the role of glutathione conjugation in TPT-induced changes in sulfobromophthalein (BSP) excretion.
Main Methods:
- Rats were treated with triphenyl tin (TPT) at 1 mg/kg i.p. daily for 3 days.
- In vitro hepatic microsomal aniline hydroxylase and aminopyrine N-demethylase activities were measured.
- Biliary excretion of sulfobromophthalein (BSP), procainamide ethobromide, and amaranth was assessed.
- Hepatic glutathione-S-transferase activity was also evaluated.
Main Results:
- TPT treatment significantly reduced hepatic microsomal aniline hydroxylase and aminopyrine N-demethylase activities.
- Biliary excretion of sulfobromophthalein (BSP) was significantly decreased in TPT-treated rats.
- TPT did not affect bile flow, liver weight, serum enzyme activities, or the biliary excretion of procainamide ethobromide and amaranth.
- TPT inhibited rat liver glutathione-S-transferase activity.
Conclusions:
- Triphenyl tin (TPT) impairs hepatic microsomal enzyme activities and reduces the biliary excretion of sulfobromophthalein (BSP) in rats.
- Reduced glutathione conjugation, due to TPT's inhibition of glutathione-S-transferase, likely contributes to the decreased biliary BSP excretion.
- TPT's effects are specific to certain metabolic pathways, as other excretory functions remained unaffected.